Wealth Growth Daily

Health

Pfizer makes equity investment in Caribou Biosciences

BY Reuters  • July 6, 2023July 6, 2023
(Reuters) – Pfizer has invested $25 million to buy a minority stake in Caribou Biosciences, making it the latest small biotechnology firm to attract the pharmaceutical giant’s interest. Th[...]
Read more
Asia Australia Business Economy Health Updated US

AI robots could play future role as companions in care homes

BY Reuters  • July 6, 2023July 6, 2023
By Emma Farge GENEVA (Reuters) – Nadine, a social robot powered by Artificial Intelligence (AI) with human-like gestures and expressions, could have an important future role to play in tending t[...]
Read more
Asia Business Entertainment and Lifestyle Europe Health Oddly Enough Science Technology Top News Updated

Generali buys U.S. asset manager Conning under deal with Cathay Life

BY Reuters  • July 6, 2023July 6, 2023
MILAN (Reuters) – Generali has agreed to buy Connecticut-based asset manager Conning Holdings as part of a partnership with Cathay Life, a unit of Taiwan’s Cathay Financial Holding, the It[...]
Read more
Asia Business Economy Europe Health

Chinese rush to buy Hong Kong insurance, dollars as confidence cracks, yuan weakens

BY Reuters  • July 6, 2023July 6, 2023
SHANGHAI/HONG KONG (Reuters) – Chinese investors are rushing offshore to make dollar deposits and buy Hong Kong insurance in a signal domestic confidence is languishing and that the ailing yuan[...]
Read more
Asia Business Economy Health Updated

EV batteries remain major challenge for insurers – UK’s Thatcham

BY Reuters  • July 5, 2023July 5, 2023
By Nick Carey LONDON (Reuters) -A lack of data on electric vehicle (EV) batteries continues to challenge insurers who are forced to scrap EVs after mild accidents, potentially undermining EV adoption,[...]
Read more
Business Economy Europe Health UK Updated

Samsung Biologics unveils $920 million manufacturing deals for Pfizer

BY Reuters  • July 4, 2023July 4, 2023
SEOUL (Reuters) – South Korea’s Samsung Biologics announced on Tuesday two deals with Pfizer worth around a combined 1.2 trillion won ($921.38 million) to manufacture products for the U.S.[...]
Read more
Asia Business Health US

AstraZeneca shares drop as lung cancer trial update lags expectations

BY Reuters  • July 3, 2023July 3, 2023
By Maggie Fick and Ludwig Burger (Reuters) – AstraZeneca said on Monday an experimental precision drug slowed progression of lung cancer in a late-stage trial, but the company’s shares fel[...]
Read more
Business Health Updated

Sandoz launches rival version of AbbVie’s arthritis drug Humira

BY Reuters  • July 1, 2023July 1, 2023
(Reuters) – Swiss drugmaker Sandoz said on Saturday it had launched a biosimilar version of AbbVie Inc’s big selling arthritis treatment Humira, adding to U.S. competition for the drug tha[...]
Read more
Asia Business Economy Europe Health US

Consumers, food-makers face choice as WHO cancer agency set to warn on aspartame sweeteners (June 29)

BY Reuters  • June 30, 2023June 30, 2023
(Corrects June 29 story to remove reference to aspartame in Weight Watchers yoghurts in paragraph 6) By Richa Naidu and Savyata Mishra LONDON (Reuters) -Consumers, food companies, retailers and restau[...]
Read more
Business Europe Health Top News Updated
« Previous 1 2 3 4 5 … 52 Next »
Wealth Growth Daily
PRIVACY POLICY

Copyright © 2026 Wealth Growth Daily. All Rights Reserved.

HIGH RISK WARNING

Trading foreign exchange, stocks, options, or futures on margin carries a high level of risk, and may not be suitable for all investors. Before deciding to trade, you should carefully consider your objectives, financial situation, needs and level of experience. Wealth Growth Daily provides general advice that does not take into account your objectives, financial situation or needs. The content of this website must not be construed as personal advice. The possibility exists that you could sustain a loss in excess of your deposited funds and therefore, you should not speculate with capital that you cannot afford to lose. You should be aware of all the risks associated with trading on margin. You should seek advice from an independent financial advisor. Past performance is not necessarily indicative of future success.

101 Marketside Ave. Suite 404 PMB 318 Ponte Vedra, FL 32081 | (321) 325-1551